Moreover, Linc01119 was found to stimulate the expression of the suppressor of cytokine signaling 5 (SOCS5) which inhibits the Janus activated kinase (JAK1/2) and the phosphorylation of signal transducer and activator of transcription (STAT1/3) pathway, thus promoting breast cancer cell growth in vitro and tumorigenesis in vivo [68,69,70,71]. This evidence concerns the gene SOCS5 and breast cancer.